Molecular Partners' CEO is Patrick Amstutz, appointed in Jan 2004, has a tenure of 22.42 years. total yearly compensation is CHF1.05M, comprised of 37% salary and 63% bonuses, including company stock and options. directly owns 2.03% of the company’s shares, worth €2.49M. The average tenure of the management team and the board of directors is 3.8 years and 5.2 years respectively.
Key information
Patrick Amstutz
Chief executive officer
CHF 1.1m
Total compensation
CEO salary percentage
37.05%
CEO tenure
22.4yrs
CEO ownership
2.0%
Management average tenure
3.8yrs
Board average tenure
5.2yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Patrick Amstutz's remuneration changed compared to Molecular Partners's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-CHF 58m
Dec 31 2025
CHF 1m
CHF 389k
-CHF 62m
Sep 30 2025
n/a
n/a
-CHF 60m
Jun 30 2025
n/a
n/a
-CHF 65m
Mar 31 2025
n/a
n/a
-CHF 59m
Dec 31 2024
CHF 1m
CHF 385k
-CHF 54m
Sep 30 2024
n/a
n/a
-CHF 63m
Jun 30 2024
n/a
n/a
-CHF 58m
Mar 31 2024
n/a
n/a
-CHF 59m
Dec 31 2023
CHF 1m
CHF 385k
-CHF 62m
Sep 30 2023
n/a
n/a
-CHF 60m
Jun 30 2023
n/a
n/a
-CHF 62m
Mar 31 2023
n/a
n/a
-CHF 50m
Dec 31 2022
CHF 1m
CHF 383k
CHF 118m
Sep 30 2022
n/a
n/a
CHF 117m
Jun 30 2022
n/a
n/a
CHF 118m
Mar 31 2022
n/a
n/a
CHF 106m
Dec 31 2021
CHF 1m
CHF 380k
-CHF 64m
Sep 30 2021
n/a
n/a
-CHF 67m
Jun 30 2021
n/a
n/a
-CHF 72m
Mar 31 2021
n/a
n/a
-CHF 66m
Dec 31 2020
CHF 1m
CHF 380k
-CHF 63m
Sep 30 2020
n/a
n/a
-CHF 53m
Jun 30 2020
n/a
n/a
-CHF 48m
Mar 31 2020
n/a
n/a
-CHF 43m
Dec 31 2019
CHF 930k
CHF 363k
-CHF 36m
Compensation vs Market: Patrick's total compensation ($USD1.34M) is above average for companies of similar size in the German market ($USD453.65K).
Compensation vs Earnings: Patrick's compensation has been consistent with company performance over the past year.
CEO
Patrick Amstutz (51 yo)
22.4yrs
Tenure
CHF 1,050,000
Compensation
Dr. Patrick Amstutz, Ph.D. is a Co-Founder of Molecular Partners AG and has been its Chief Executive Officer since November 2016 and serves as its Member of Management Board since 2004. Dr. Amstutz serves...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Patrick Amstutz
Co-Founder
22.4yrs
CHF 1.05m
2.03% € 2.5m
Michael Stumpp
Co-Founder
22.4yrs
no data
1.93% € 2.4m
Robert Hendriks
Senior VP of Finance & Member of Management Board
6.9yrs
no data
no data
Alexander Zurcher
COO & Member of Management Board
3.9yrs
no data
0.060% € 74.0k
Renate Gloggner
Executive VP of People & Community and Member of Management Board
4.5yrs
no data
0.091% € 111.6k
Philippe Legenne
Chief Medical Officer & Member of the Management Board
1.4yrs
no data
0.11% € 135.5k
Martin Steegmaier
Chief Scientific Officer & Member of the Management Board
less than a year
no data
no data
Michael Pitzner
Executive VP of Partnering & General Counsel
3.6yrs
no data
no data
Pamela Trail
Strategic Consultant
6.9yrs
no data
no data
Daniel Steiner
Senior Vice President of Targeted Radio Therapeutics
less than a year
no data
no data
Seth Lewis
Executive Vice President of Corporate Finance
less than a year
no data
no data
Laura Jeanbart
Head of Portfolio Management & Corporate Communications
1.4yrs
no data
no data
3.8yrs
Average Tenure
56yo
Average Age
Experienced Management: 6ML's management team is considered experienced (3.8 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Patrick Amstutz
Co-Founder
8.7yrs
CHF 1.05m
2.03% € 2.5m
William Burns
Independent Chairman of the Board
8.7yrs
CHF 295.00k
0.11% € 134.2k
Vito Palombella
Independent Director
6.2yrs
CHF 128.00k
0.024% € 29.7k
Agnete Fredriksen
Independent Director
5.2yrs
CHF 138.00k
0.015% € 18.2k
Michael Vasconcelles
Independent Director
6.2yrs
CHF 138.00k
0.024% € 29.7k
Sandip Kapadia
Independent Director
6.2yrs
CHF 133.00k
0.024% € 29.7k
Jason Lewis
Member of Scientific Advisory Board
less than a year
no data
no data
Clare Fisher
Director
less than a year
no data
no data
Ken Herrmann
Chairman of Scientific Advisory Board
less than a year
no data
no data
Dominik Hochli
Independent Director
5.2yrs
CHF 138.00k
0.013% € 16.3k
James Cook
Member of Scientific Advisory Board
less than a year
no data
no data
Michael Morris
Member of Scientific Advisory Board
less than a year
no data
no data
5.2yrs
Average Tenure
56yo
Average Age
Experienced Board: 6ML's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/02 05:03
End of Day Share Price
2026/06/02 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Molecular Partners AG is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.